TBPH Bathi mangsa ngarep Theravance Biopharma Inc

Simbol resmi perusahaan Theravance Biopharma Inc (TBPH)

Stable royalties ensure predictable cash flows for Theravance Biopharma (TBPH). The business model relies on outsourcing distribution and the commercial scaling of drugs through major partners, maintaining a strategic focus on R&D. The company's earnings expectations confirm this approach, with the current mark standing at 0.09. Investors' pragmatic perception solidifies its status as a reliable developer of respiratory therapy treatments.

theravance.com (TBPH): Bathi resik sing dikarepake saka 04.07.2022 nganti 10.10.2026

Theravance - rincian analitis lan metrik utama (TBPH)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:TBPH, Theravance Biopharma, Inc.
Produk dadi Theravance Biopharma Inc

For Theravance Biopharma (TBPH), which relies on fundamental R&D stability and an academic approach to drug development, an analysis of projected financial results allows for an assessment of the effectiveness of long-term investments in scientific personnel. This indicator synthesizes market expectations for net income, transforming the daily balance of supply and demand into a vector of future capital value, which helps investors recognize an overbought asset in a timely manner.

Analisis pesaing Theravance Biopharma

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Proyeksi bathi mangsa ngarep Aquestive Corp AQST|scPharmaceuticals - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Bathi sing dikarepake|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan